Mark Borden
- The collaborative work could boost health and drug advancements by giving researchers a better understanding of primary and secondary radiation forces in multiphase colloidal systems – such as emulsions, foams, membranes and gels.
- After a year when the nation experienced a shortage of mechanical ventilators to help treat patients with severe COVID-19 complications, Professor Mark Borden's company Respirogen presents another treatment option: oxygen microbubbles.
- John Myers (MBioEngr’21) was the first student to graduate from the Biomedical Engineering Program with a thesis-based master’s degree. Now, he has a more competitive edge as he plans his future education and career.
- Two faculty members with the Biomedical Engineering Program have received grants from the ÃÛÌÇÖ±²¥ Clinical and Translational Science Institute (CCTSI). CCTSI awarded BME Program Director Mark Borden and Associate Professor Virginia Ferguson two